Amrita Sule
0000-0001-6782-1899
Yale University
8 papers found
Refreshing results…
Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors
Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma
PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice
Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
Radiosensitizing Glioma by Targeting ATM with Small Molecule Inhibitors
Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
Missing publications? Search for publications with a matching author name.